Companies: 10,795·Total market cap: $144.5T

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc.

SLSNASDAQHealthcare● Active

$7.98

$-0.25(-3.04%)

Market Cap$1.1B

P/E Ratio—

52W High$9.51

52W Low$1.39

Avg Volume7.9M

Open$8.51

Beta2.53

Net Income Financials Revenue

SELLAS Life Sciences Group, Inc. (SLS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

SLS · net income · updated Jun 9, 2026

Core profitability metrics

SLS · net income · margin · TTM · CAGR

Net income was −$26.9M for FY2025 (fiscal year ending 2025-12-31), up 13.0% year-over-year. Net profit margin was —.

FY2025 Net Income−$26.9M▲ +13.0% YoY

Trailing 12M (TTM)−$29.5Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+13.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · SLS net income history · SLS profit margin

Annual net income data

SLS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$26.9M▲ +13.0%—$0

FY2024Loss−$30.9M▲ +17.3%—$0

FY2023Loss−$37.3M▲ +9.6%—$0

FY2022Loss−$41.3M▼ 99.5%-4130.1%$1.0M

FY2021Loss−$20.7M▼ 23.5%-272.4%$7.6M

Net income vs peers (Healthcare)

SLS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

SELLAS Life Sciences Group, Inc.YOU

SLS

−$26.9M+13.0%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

SELLAS Life Sciences Group, Inc. (SLS) reported net income of −$26.9M for FY2025 (fiscal year ending 2025-12-31), up 13.0% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

SELLAS Life Sciences Group, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

SELLAS Life Sciences Group, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "SELLAS Life Sciences Group, Inc. net worth" — the company's market capitalization is a separate figure from SLS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

SLS net income · 4 questions

SELLAS Life Sciences Group, Inc. is not currently profitable on an annual basis. The company reported a net loss of $26.9M for FY2025.

is SLS profitabledoes SLS make a profitSLS profitabilitySLS profitable company

▸ Source: FMP /income-statement · GAAP · SELLAS Life Sciences Group, Inc. · SELLAS Life Sciences Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026